Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06587412

Treatment of Lateral Epicondylalgia With Shock Waves

Radial Shock Waves Versus Focal Shock Waves in the Treatment of Lateral Epicondylalgia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Alcala · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Lateral epicondylalgia (LET) is characterized by pain, decreased muscle strength of the wrist extensor muscles, and disability. Among the treatments proposed in the literature, both focal shockwave therapy and radial shockwave therapy have been considered effective in the management of this musculoskeletal disorder. The objective of this study is to compare the safety and effectiveness of these two shockwave applications on the signs and symptoms of subjects with lateral epicondylalgia. In this clinical trial, subjects will be evaluated for elbow pain using a Visual Analog Scale (VAS), grip strength using a handheld dynamometer, and degree of disability using the Patient-Rated Tennis Elbow Evaluation Questionnaire (PRTEE). A six-month follow-up will be performed. Patients will be randomly divided into three groups. The first group will receive radial shock waves (rESWT), the second group will receive focal shock waves (fESWT), and the third group, which will act as a control, will receive a placebo treatment with very low energy parameters according to the literature. Subjects will receive three sessions, one session per week.

Conditions

Interventions

TypeNameDescription
OTHERRadial shock waves treatmentSubjects in this group will receive radial shock waves
OTHERFocal Shock Waves treatmentSubjects in this group will receive focal shock waves
OTHERshock waves placebo treatmentSubjects in this group will receive a shock waves placebo treatment with very low energy settings

Timeline

Start date
2025-03-12
Primary completion
2025-09-20
Completion
2025-12-20
First posted
2024-09-19
Last updated
2025-03-13

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06587412. Inclusion in this directory is not an endorsement.